China Cancer Drug Misuse In Spotlight After Shocking Whistleblower Tales

Using PD-1 immuno-oncology drugs to treat post-surgery gastric cancer and prescribing unapproved targeted therapies for colon cancer are just two examples of the apparently widespread misuse of oncology drugs in China, as alleged by an oncologist at a prestigious Peking university hospital.

cancer therapy

Citing widespread and overly aggressive medical practice in treating patients, and physicians' imprudent decisions, a prominent oncologist in China has openly criticized a lack of oversight, non-compliance with well-established guidelines and the misuse of cancer drugs in pursuit of personal financial gain.

In a widely circulated open letter, Zhang Yi, a specialist at the clinical oncology department of Beijing's Peking University No.3 Hospital, said he could not remain quiet anymore after pondering over the past year some of the issues he has witnessed during his daily work as a clinical oncologist

More from Global Vision

More from In Vivo